Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)

NACompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Diabetic Ketoacidosis
Interventions
DEVICE

DEXCOM G6 CGM

Continuous glucose monitoring

Trial Locations (1)

10032

New York Presbyterian Hospital/ Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Columbia University

OTHER